RELIPOIETIN 5000IU PFS

About

Relipoietin is a recombinant human erythropoietin (rHuEPO) that stimulates erythropoiesis, the production of red blood cells, in the bone marrow. It functions identically to the naturally occurring hormone, which is primarily produced by the kidneys in response to hypoxia. By binding to erythropoietin receptors on erythroid progenitor cells, Relipoietin promotes their proliferation, differentiation, and maturation into mature red blood cells. This action effectively increases hemoglobin levels and red blood cell mass, thereby improving oxygen-carrying capacity and alleviating symptoms of anemia. It is particularly vital for patients with chronic kidney disease, where endogenous erythropoietin production is often impaired, leading to significant anemia. The pre-filled syringe formulation ensures convenient and accurate dosing.

Uses

• Treatment of anemia associated with chronic kidney disease (CKD).
• Treatment of anemia in cancer patients receiving chemotherapy.
• Reduction of allogeneic blood transfusions in surgery patients.
• Treatment of anemia in HIV-infected patients receiving zidovudine.

Directions For Use

Administer subcutaneously or intravenously as directed by a healthcare professional. Dosage is individualized based on hemoglobin levels and patient response.

Benefits

• Increases red blood cell count.
• Elevates hemoglobin levels.
• Reduces need for blood transfusions.
• Improves quality of life in anemic patients.
• Alleviates symptoms of anemia (fatigue, shortness of breath).
• Convenient pre-filled syringe (PFS) for ease of use.

Side Effects

• Hypertension (high blood pressure)
• Thrombotic events (e.g., DVT, stroke, MI)
• Headache
• Fever
• Nausea
• Vomiting
• Diarrhea
• Injection site pain
• Rash
• Seizures
• Pure red cell aplasia (rare)
• Flu-like symptoms

Safety Measures

• Alcohol - No direct interaction with alcohol, but excessive alcohol use can worsen anemia or liver function.
• Pregnancy - Use with caution during pregnancy; benefits must outweigh potential risks. Consult a physician.
• Breastfeeding - It is unknown if epoetin alfa is excreted in human milk. Use with caution.
• Liver - Use with caution in patients with severe liver disease; monitor liver function.
• Kidney - Primarily used for anemia in CKD, but monitor kidney function and blood pressure closely.
• Lung - No specific contraindications related to lung conditions, but monitor for thrombotic events.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.